
Sign up to save your podcasts
Or


Apple falls after CEO Tim Cook lowers revenue guidance for the 1st quarter. Bristol-Myers Squibb gives Celgene shareholders $74 billion reasons to smile. MFAM Funds portfolio manager Bill Barker analyzes the latest headlines and what it means for investors. Plus, we dip into the Fool Mailbag to discuss investing for your (adult) children. (Tangents include company rebranding fails, Harry Potter’s effect on today’s mega-merger, and why Bill hasn’t been in the studio in awhile.)
By The Motley Fool4.7
16041,604 ratings
Apple falls after CEO Tim Cook lowers revenue guidance for the 1st quarter. Bristol-Myers Squibb gives Celgene shareholders $74 billion reasons to smile. MFAM Funds portfolio manager Bill Barker analyzes the latest headlines and what it means for investors. Plus, we dip into the Fool Mailbag to discuss investing for your (adult) children. (Tangents include company rebranding fails, Harry Potter’s effect on today’s mega-merger, and why Bill hasn’t been in the studio in awhile.)

3,235 Listeners

1,496 Listeners

806 Listeners

942 Listeners

531 Listeners

1,181 Listeners

2,184 Listeners

825 Listeners

1,429 Listeners

1,051 Listeners

9,714 Listeners

195 Listeners

829 Listeners

83 Listeners

589 Listeners

1,022 Listeners

50 Listeners